ABBV-9697 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

450 results for “ABBV-9697”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Study to Assess Adverse Events and Compare How Two Subcutaneous ABBV-154 Injection Formulations Move Through the Body of Adult Healthy Participants

40 participants · First posted Sep 27, 2022

Active, not recruiting

A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer

152 participants · First posted Mar 19, 2024

A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222

78 participants · First posted May 31, 2019

Active, not recruiting

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

163 participants · First posted Dec 12, 2016

No Longer Available

Expanded Access to ABBV-787

First posted Jun 3, 2024

Expanded Access to ABBV-706

First posted Dec 30, 2025

No Longer Available

Expanded Access to ABBV-8E12

First posted Nov 16, 2018

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

60 participants · First posted Apr 18, 2025

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

139 participants · First posted Mar 7, 2017

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

5 participants · First posted Mar 18, 2021

Page 1 of 24